Here's Why Walt Disney (DIS) is a Strong Value Stock — Positive

DIS   Zacks Investment Research — January 12, 2026

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Here's Why Walt Disney (DIS) is a Strong Value Stock

Should Value Investors Buy Lindblad Expeditions (LIND) Stock? — Positive

LIND   Zacks Investment Research — January 12, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Should Value Investors Buy Lindblad Expeditions (LIND) Stock?

Here's Why Cheesecake Factory (CAKE) is a Strong Value Stock — Positive

CAKE   Zacks Investment Research — January 12, 2026

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why Cheesecake Factory (CAKE) is a Strong Value Stock

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? — Positive

COLL   Zacks Investment Research — January 12, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term — Positive

TEVA   Zacks Investment Research — January 12, 2026

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term

Should Value Investors Buy Cardinal Health (CAH) Stock? — Positive

CAH   Zacks Investment Research — January 12, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Should Value Investors Buy Cardinal Health (CAH) Stock?

Why T. Rowe Price (TROW) is a Top Value Stock for the Long-Term — Positive

TROW   Zacks Investment Research — January 12, 2026

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Why T. Rowe Price (TROW) is a Top Value Stock for the Long-Term

Here's Why Leidos (LDOS) is a Strong Value Stock — Positive

LDOS   Zacks Investment Research — January 12, 2026

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Here's Why Leidos (LDOS) is a Strong Value Stock

Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term — Positive

UHS   Zacks Investment Research — January 12, 2026

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term

Is Edison International (EIX) Stock Undervalued Right Now? — Positive

EIX   Zacks Investment Research — January 12, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Is Edison International (EIX) Stock Undervalued Right Now?

Should Value Investors Buy Rayonier Advanced Materials (RYAM) Stock? — Positive

RYAM   Zacks Investment Research — January 12, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Should Value Investors Buy Rayonier Advanced Materials (RYAM) Stock?

Is Evertec (EVTC) Stock Undervalued Right Now? — Positive

EVTC   Zacks Investment Research — January 12, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Is Evertec (EVTC) Stock Undervalued Right Now?

Are Investors Undervaluing Host Hotels & Resorts (HST) Right Now? — Positive

HST   Zacks Investment Research — January 12, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Are Investors Undervaluing Host Hotels & Resorts (HST) Right Now?

INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced — Positive

INSM   Zacks Investment Research — January 12, 2026

Shares of Insmed rise after it tops FY25 sales forecasts, led by strong Brinsupri uptake, and outlines 2026 guidance and pipeline milestones.

image for news INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced

Can Estee Lauder's Fragrance Strength Drive Top-Line Growth? — Positive

EL   Zacks Investment Research — January 12, 2026

EL sees fragrance emerge as its strongest category, helping drive a return to positive organic sales growth in the fiscal first quarter.

image for news Can Estee Lauder's Fragrance Strength Drive Top-Line Growth?

Exelixis Posts Preliminary '25 Results, Issues '26 Outlook — Neutral

EXEL   Zacks Investment Research — January 12, 2026

EXEL posts approximately $2.32B in 2025 revenues and guides $2.525 -$2.625B for 2026 as Cabometyx grows and a zanzalintinib NDA advances.

image for news Exelixis Posts Preliminary '25 Results, Issues '26 Outlook

SMCI Plunges 45% in 3 Months: Time to Buy, Sell or Hold the Stock? — Neutral

SMCI   Zacks Investment Research — January 12, 2026

Super Micro Computer shares are down nearly 45% in three months, trading at a discounted P/E as margins compress, cash flow weakens, and AI expansion drives a Hold view.

image for news SMCI Plunges 45% in 3 Months: Time to Buy, Sell or Hold the Stock?

Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) — Positive

ANGO   Zacks Investment Research — January 12, 2026

AngioDynamics (ANGO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

image for news Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)

Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround — Positive

AQST   Zacks Investment Research — January 12, 2026

Aquestive Therapeutics (AQST) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

image for news Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround

SharkNinja, Inc. (SN) Presents at ICR Conference 2026 Transcript — Neutral

SN   Seeking Alpha — January 12, 2026

SharkNinja, Inc. (SN) Presents at ICR Conference 2026 Transcript

image for news SharkNinja, Inc. (SN) Presents at ICR Conference 2026 Transcript